BioXcel Therapeutics (BTAI) Return on Capital Employed Growth (1y) (2019 - 2026)
BioXcel Therapeutics (BTAI) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 | -427,432.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -427,432.00 |
| Mar 31, 2026 | 73,792.00 |
| Dec 31, 2025 | 87,072.00 |
| Sep 30, 2025 | 225,843.00 |
| Jun 30, 2025 | 455,212.00 |
| Mar 31, 2025 | -10,099.00 |
| Dec 31, 2024 | -2,727.00 |
| Sep 30, 2024 | 1,082.00 |
| Jun 30, 2024 | -7,935.00 |
| Mar 31, 2024 | -20,185.00 |
| Dec 31, 2023 | -20,426.00 |
| Sep 30, 2023 | -19,371.00 |
| Jun 30, 2023 | -9,837.00 |
| Mar 31, 2023 | -5,568.00 |
| Dec 31, 2022 | -3,721.00 |
| Sep 30, 2022 | -1,984.00 |
| Jun 30, 2022 | -1,384.00 |
| Mar 31, 2022 | -619.00 |
| Dec 31, 2021 | -792.00 |
| Sep 30, 2021 | 1,064.00 |